May 13, 2009 – Siemens Healthcare is demonstrating the clinical benefits of the world’s first volume intracardiac echocardiography (VICE) catheter, the ACUSON AcuNav V ultrasound catheter, this week at the 2009 Scientific Sessions of the Heart Rhythm Society in Boston, May 13-16.

May 13, 2009 - NewCardio Inc. this week is introducing the QTinno, an automated analysis of ECGs used to determine cardiac toxicity during drug development, and the Visual3Dx, which generates 3D information from the heart using standard 12-lead ECG data, during Heart Rhythm 2009 in Boston.

May 13, 2009 – Stereotaxis Inc. said this week the Heart Rhythm 2009 formal program contains 21 podium and poster presentations in which its Niobe system is either featured or discussed regarding the treatment of complex cardiac arrhythmias.

May 13, 2009 - Medtronic Inc. today announced the start of a nationwide trial to examine the relationship between the company’s OptiVol Fluid Status Monitoring technology and the ability to predict worsening heart failure, a leading cause of hospitalizations worldwide.

May 13, 2009 - St. Jude Medical Inc. today said it will display a number of new products and technologies at the annual Heart Rhythm Society meeting in Boston this week, including therapies and devices for the treatment of heart arrhythmias, including products enabled with wireless connectivity.

May 12, 2009 - PETLinQ LLC, a radiology solutions provider, released its newest product innovation - SoftStationWeb - a thin client web-based application created for the viewing of full PET/CT data sets with fused images, requiring only a secure password and login; no downloading of any kind is needed.

May 11, 2009 - With 12 million Americans at risk for sudden cardiac arrest (SCA), Cambridge Heart’s Microvolt T-Wave Alternans (MTWA) diagnostic test reportedly offers a cost-effective treadmill test to identify those at high or low risk.

May 11, 2009 - Medtronic Inc. today announced the successful implant of its Cardioblate Closure Left Atrial Appendage Occlusion Device by Patrick McCarthy, M.D., co-director of the Bluhm Cardiovascular Institute at Northwestern Memorial Hospital in Chicago, Ill., as part of a U.S. clinical trial.

Edwards offers the PORT ACCESS EndoDirect System, which allows cardiac surgeons to stop a patient's heart and keep it at rest for the duration of the heart valve procedure without an incision down the middle of the chest.

May 10, 2009 - Edwards Lifesciences Corp. Friday said it received clearance from the FDA for the Carpentier-Edwards PERIMOUNT Magna Ease aortic valve, designed for easier implantation in the heart.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now